1. International Conference on Harmonisation. Guidance for industry. E6 good clinical practice: consolidated guidance. http://www.fda.gov/downloads/Drugs/Guidances/ucm073122.pdf . Accessed 12 Mar 2015.
2. Clinical research India: the need for education and training. J Clin Stud. 2008:22–27. http://www.cliniminds.com/presentation/pdffiles/JCSs.pdf . Accessed 12 Mar 2015.
3. Ministry of Health and Family Welfare. Drugs and cosmetics (IInd amendment) rules, 2005. New Delhi: Department of Health. 2005. http://dbtbiosafety.nic.in/act/scheduley.pdf . Accessed 14 Mar 2015.
4. Department-Related Standing Committee on Health And Family Welfare. Fifty-ninth report on the functioning of the Central Drugs Standard Control Organisation (CDSCO). New Delhi: Rajya Sabha Secretariat. 2012. http://164.100.47.5/newcommittee/reports/englishcommittees/committee%20on%20health%20and%20family%20welfare/59.pdf . Accessed 7 Sept 2015.
5. Sayeeda R. Managing clinical trials in Asia: issues, threats, opportunities and approaches. South East Asia J Public Health. 2012;2(2):80–84. http://www.banglajol.info/index.php/SEAJPH/article/download/15961/11333 . Accessed 10 Sept 2015.